Acute treatment of bipolar disorder with adjunctive risperidone in outpatients

Canadian Journal of Psychiatry

Volumn 42, Issue 2, 1997, Pages 196-199

  Ghaemi, S Nassir ^a,d   Sachs, Gary S ^b,c   Baldassano, Claudia F ^b,c   Truman, Christine J ^b,c  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

bipolar disorder; drug therapy; risperidone

Indexed keywords

RISPERIDONE;

ADULT; AKATHISIA; AMNESIA; ARTICLE; ATAXIA; BIPOLAR DEPRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; MALE; NAUSEA; SEXUAL DYSFUNCTION; VERTIGO; WEIGHT GAIN;

EID: 0030892725     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674379704200211     Document Type: Article

References (15)

1. Ghaemi SN, Sachs GS, Baldassano CF. Treatment-resistant bipolar disorder: clinical aspects and management. In: Pollack M, Rosenbaum JF, editors. Challenges in psychiatric treatment: pharmacologic and psychosocial strategies. New York: Guilford; 1996. p 53-85.
2. Sernyak MJ, Griffin RA, Johnson RM, Pearsall HR, Wexler BE, Woods SW. Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic. Am J Psychiatry 1994;151:133-5.
3. Marder SR, Van Putten T. Antipsychotic medications. In: Schatzberg AF, Nemeroff CB, editors. Textbook of psychopharmacology. Washington (DC): American Psychiatric Press; 1995. p 247-62.
4. Saltz BL, Woerner MG, Kane JM, Lieberman JA, Alvir JMJ, Bergmann KJ, and others. Prospective study of tardive dyskinesia in the elderly. JAMA 1991; 266:2402-6.
5. Suppes T, McElroy SL, Gilbert J, Dessain EC, Cole JO. Clozapine in the treatment of dysphoric mania. Biol Psychiatry 1992;32:270-80.
6. McElroy SL, Dessain EC, Pope HG, Cole JO, Keck PE, Frankenburg FR, and others. Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 1991;52:411-4.
7. Banov MD, Zarate CA, Tohen MDS, Wines JD, Kolbrener M, Kim J, and others. Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up. J Clin Psychiatry 1994;55:295-300.
8. Kimmel SE, Calabrese JR, Woyshville MJ, Meltzer HY. Clozapine in treatment-refractory mood disorders. J Clin Psychiatry 1994;55(9 Suppl B):91-3.
9. Spitzer R, Williams J, Gibbon M, First M. Structured Clinical Interview for DSM-III-R-Patient Edition (SCID-P, Version 1.0). Washington (DC): American Psychiatric Press; 1990.
10. Overall J, Gorham D. The Brief Psychiatric Rating Scale. Psychol Rep 1962; 10:799-812.
11. Tohen M, Zarate CA, Centorrino F, Hegary J, Froeschl M, Zarate SB. Risperidone in the treatment of mania. J Clin Psychiatry 1996;57:249-53.
12. Jacobsen FM. Risperidone in the treatment of affective illness and obsessive-compulsive disorder. J Clin Psychiatry 1995;56:423-9.
13. Keck PE Jr, Wilson DR, Strakowski SM, McElroy SL, Kizer DL, Balistreri TM, and others. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders. J Clin Psychiatry 1995; 56:466-71.
14. Dwight MM, Keck PE, Stanton SP, Strakowski SM, McElroy SL. Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder [letter]. Lancet 1994;344:554-5.
15. Keck PE. Schizoaffective patients. In: Antipsychotic drug therapy: current status. J Clin Psychiatry Monograph Series 1995;13:24-7.